https://orcid.org/0000-0001-8456-744X
References
- Burnier M, Fricker AF, Hayoz D, et al. Pharmacokinetic and pharmacodynamic effects of YM087, a combined V1/V2 vasopressin receptor antagonist in normal subjects. Eur J Clin Pharmacol. 1999;55(9):633–637. doi:10.1007/s002280050685
- Decaux G. Long-term treatment of patients with inappropriate secretion of antidiuretic hormone by the vasopressin receptor antagonist conivaptan, urea, or furosemide. Am J Med. 2001;110(7):582–584. doi:10.1016/S0002-9343(01)00678-7
- Baldini E, Odorisio T, Sorrenti S, et al. Vitiligo and autoimmune thyroid disorders. Front Endocrinol. 2017;8:290. doi:10.3389/fendo.2017.00290
- Zhang Z, Xu SX, Zhang FY, et al. The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients. Arch Dermatol Res. 2009;301(2):167–173. doi:10.1007/s00403-008-0900-z
- Fried LF, Palevsky PM. Hyponatremia and hypernatremia. Med Clin North Am. 1997;81(3):585–609. doi:10.1016/S0025-7125(05)70535-6
- US Food and Drug Authority. Vaprisol; [July 4, 2021]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021697lbl.pdf. Accessed October 29, 2021.
- Gheorghiade M, Konstam MA, Burnett JC Jr, et al. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST clinical status trials. JAMA. 2007;297(12):1332–1343. doi:10.1001/jama.297.12.1332
- Krüger CS, Challreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol. 2012;51(10):1206–1212. doi:10.1111/j.1365-4632.2011.05377.x
- Carrington AE, Kitts S, Kleinwaks E, et al. Vitiligo on YouTube: a cross-sectional analysis. J Am Acad Dermatol. 2021. doi:10.1016/j.jaad.2021.01.062
- Pithadia DJ, Reynolds KA, Lee EB, et al. A cross-sectional study of YouTube videos as a source of patient information about phototherapy and excimer laser for psoriasis. J Dermatolog Treat. 2020;31(7):707–710. doi:10.1080/09546634.2019.1605144
- Borba AJ, Young PM, Read C, et al. Engaging but inaccurate: a cross-sectional analysis of acne videos on social media from non-health care sources. J Am Acad Dermatol. 2020;83(2):610–612. doi:10.1016/j.jaad.2019.08.035
- Gorrepati PL, Smith GP. DISCERN scores of YouTube information on eczema treatments. J Am Acad Dermatol. 2020. doi:10.1016/j.jaad.2020.11.007
- Laughter M, Zangara T, Maymone M, et al. Social media use in dermatology. Dermatol Sin. 2020;38(1):28–34. doi:10.4103/ds.ds_43_19
- Read C, Wu KK, Young PM, et al. Vitiligo health education: a study of accuracy and engagement of online educational materials. J Drugs Dermatol. 2021;20(6):623–629.
- Delli K, Livas C, Vissink A, et al. Is YouTube useful as a source of information for Sjögren’s syndrome? Oral Dis. 2016;22(3):196–201. doi:10.1111/odi.12404
- Charnock D, Shepperd S, Needham G, et al. DISCERN: an instrument for judging the quality of written consumer health information on treatment choices. J Epidemiol Community Health. 1999;53(2):105–111. doi:10.1136/jech.53.2.105
- Chen AY, Azizi B, Borba AJ, et al. Rosacea videos on social media: a comparison of accuracy, quality, and viewer engagement. Dermatol Online J. 2021;27(2). doi:10.5070/D3272052381
- Szmuda T, Syed MT, Singh A, et al. YouTube as a source of patient information for Coronavirus Disease (COVID-19): a content-quality and audience engagement analysis. Rev Med Virol. 2020;30(5):e2132.
- Brachtenbach T, Cardenas R, Pate H, et al. YouTube: searching for answers about breast cancer. Breast Dis. 2020;39(2):85–90. doi:10.3233/BD-200445
- Bergqvist C, Ezzedine K. Vitiligo: a review. Dermatology. 2020;236(6):571–592. doi:10.1159/000506103
- Eksi Ozsoy H. Evaluation of YouTube videos about smile design using the DISCERN tool and Journal of the American Medical Association benchmarks. J Prosthet Dent. 2021;125(1):151–154. doi:10.1016/j.prosdent.2019.12.016